Every year, more and more patients are receiving ICMs — all of which must be actively managed, creating additional workloads for everyone involved. BIOMONITOR III is the ICM that delivers easier and more efficient injection and monitoring, and our unique BIOvector design provides the clearest signals for easier evaluation and better informed diagnosis.
BIOTRONIK CRT-D systems offer all the options needed for implantation and therapy optimization. Plus superior solutions to provide a truly unique patient care. For optimal support along the CRT healthcare journey, the Intica 7 CRT-D series offers LV VectorOpt, MultiPole Pacing, BIOTRONIK Home Monitoring®, MRI AutoDetect, CLS and DX technology.
Evity 6 pacemakers combine small size with a complete suite of tools for comprehensive diagnostics, powerful bradycardia therapy and facilitated handling — yielding long-lasting wireless devices that support efficient MRI access and timesaving remote monitoring.
Small, Enduring, Complete, Smart — Evity 8 pacemakers combine small size with a complete suite of tools for comprehensive diagnostics, powerful bradycardia therapy and facilitated handling — yielding long-lasting wireless devices that support efficient MRI access, timesaving remote monitoring and unique physiological rate adaptation.
Enitra 6 pacemakers combine small size with a complete suite of tools for comprehensive diagnostics, powerful bradycardia therapy and facilitated handling— yielding long-lasting wireless devices that support efficient MRI access and timesaving remote monitoring.
For several decades, BIOTRONIK has consistently demonstrated innovation and excellent quality within all of its components. Excellence is at the heart of our mission, continuing to inspire us in perfecting lifelong protection for ICD patients. The Intica 7 ICD series offers BIOTRONIK Home Monitoring®, ProMRI®, MRI AutoDetect, ShockReduct, DX Technology and CLS.
Small, Enduring, Complete, Smart — Enitra 8 pacemakers combine small size with a complete suite of tools for comprehensive diagnostics, powerful bradycardia therapy and facilitated handling — yielding long-lasting wireless devices that support efficient MRI access, timesaving remote monitoring and unique physiological rate adaptation.
Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator, presented the latest results of the BIOMAG-I clinical study at the Cardiovascular Research Technologies (CRT) meeting.1 At six months the angiographic and clinical data showed a low in-scaffold late lumen loss (LLL) rate and a good safety profile with no scaffold thrombosis. A low proportion of mal-apposed struts after implantation was observed, at six months struts were no longer discernable. The intravascular imaging documented a preservation of the scaffold area with a low mean neointimal area. Bioresorbable scaffolds have been developed to provide temporary mechanical support, while controlling neointimal proliferation over the vascular healing period and preventing long-term stent-related adverse events. DREAMS 3G, BIOTRONIK’s next generation drug-eluting resorbable Magnesium scaffold (RMS), is made of a proprietary Magnesium alloy and maintains a resorption time of 12 months. Compared to its predecessor DREAMS 2G, it offers unique be
